Revance Therapeutics shares owned by Essex Woodlands Health Ventures
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Essex Woodlands Health Ventures
from 13F filings
Historical chart of Essex Woodlands Health Ventures investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Essex Woodlands Health Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Essex Woodlands Health Ventures
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $5.2M | 457k | 11.47 |
2023-06-30 | $12M | 457k | 25.31 |
2023-03-31 | $15M | 457k | 32.21 |
2022-12-31 | $8.4M | 457k | 18.46 |
2022-09-30 | $12M | 457k | 27.00 |
2022-06-30 | $6.3M | 457k | 13.82 |
2022-03-31 | $8.9M | 457k | 19.50 |
2021-12-31 | $7.5M | 457k | 16.32 |
2021-09-30 | $13M | 473k | 27.86 |
2021-06-30 | $37M | 1.3M | 27.95 |
2021-03-31 | $77M | 2.8M | 27.95 |
2020-12-31 | $95M | 3.3M | 28.34 |
2020-09-30 | $84M | 3.3M | 25.14 |
2020-06-30 | $82M | 3.3M | 24.42 |
2020-03-31 | $50M | 3.3M | 14.80 |
2019-12-31 | $54M | 3.3M | 16.23 |
2019-09-30 | $43M | 3.3M | 13.00 |
2019-06-30 | $43M | 3.3M | 12.97 |
2019-03-31 | $53M | 3.3M | 15.76 |
2018-12-31 | $92M | 3.3M | 27.45 |
2018-09-30 | $83M | 3.3M | 24.85 |
2018-06-30 | $92M | 3.3M | 27.45 |
2018-03-31 | $118M | 3.8M | 30.80 |
2017-12-31 | $137M | 3.8M | 35.75 |
2017-09-30 | $127M | 4.6M | 27.55 |
2017-06-30 | $121M | 4.6M | 26.40 |
2017-03-31 | $96M | 4.6M | 20.80 |
2016-12-31 | $95M | 4.6M | 20.70 |
2016-09-30 | $74M | 4.6M | 16.21 |
2016-06-30 | $63M | 4.6M | 13.60 |
2016-03-31 | $80M | 4.6M | 17.46 |
2015-12-31 | $157M | 4.6M | 34.16 |
2015-09-30 | $137M | 4.6M | 29.76 |
2015-06-30 | $147M | 4.6M | 31.98 |
2015-03-31 | $95M | 4.6M | 20.73 |
2014-12-31 | $78M | 4.6M | 16.94 |
2014-09-30 | $89M | 4.6M | 19.33 |
2014-06-30 | $156M | 4.6M | 34.00 |
2014-03-31 | $145M | 4.6M | 31.50 |
More positions owned by Essex Woodlands Health Ventures
View all positions for Essex Woodlands Health Ventures